Skip to main content

Critical Care Reviews Newsletter

Newsletter 490  |  May 3rd 2021

Register for the free weekly newsletter

Welcome to the 490th Critical Care Reviews Newsletter, bringing you the best critical care research and open access articles from across the medical literature over the past seven days.

The highlights of this week's edition are the RECOVERY randomised controlled trial on tocilizumab in COVID-19 & a RCT on point-of-care ultrasound of the heart and lungs in patients with respiratory failure; systematic reviews and meta analyses on therapeutic hypothermia during cardiopulmonary resuscitation & prone positioning of nonintubated patients with COVID-2019; and observational studies on the association of delirium during critical illness with mortality & recall of clinical trial participation and attrition rates in survivors of acute respiratory distress syndrome.

There are also guidelines on admission criteria and management of critical care patients in a pandemic context & the management of hospitalised adults with COVID-19; narrative reviews on interleukin-6 receptor blockade in patients with COVID-19 & comprehensive haemodynamic assessment with ultrasound; editorials on a COASTal view: where prior beliefs and uncertainty collide & paediatric intensive care challenges caused by indirect effects of the COVID-19 pandemic; and commentaries on whether the Berlin definition of acute respiratory distress syndrome should include patients receiving high-flow nasal oxygen & incorporating adult evidence into pediatric research and practice; as well as correspondence on gender differences in the provision of intensive care & expanding controlled donation after the circulatory determination of death

If you only have time to read one review article this week, try this one on pneumonia.

Research

Randomised Controlled Trials

Systematic Review & Meta Analyses

Observational Studies

Reviews

Clinical

COVID-19
Circulatory
Respiratory
Hepatobiliary
Renal
Sepsis
Trauma
Paediatrics
End-of-Life
Perioperative
Miscellaneous

Correspondence

I hope you find this newsletter useful.


Until next week

Rob

 

 

Supported by the Health Research Board